FDA allows Houston cancer doctor to resume drug trial
Por um escritor misterioso
Descrição
Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw
CV Disease Fellowship: Fellows
Promising Medical Advances in Cancer Treatment and Care
Katy Rezvani MD Anderson Cancer Center
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial - The Lancet Oncology
FDA clears MD Anderson to test skin cancer treatment on humans
Study finds why some cancer drugs may be ineffective - UTHealth News - UTHealth Houston
Hagop M. Kantarjian MD Anderson Cancer Center
World's First Gene Therapy Clinical Trial for Glycogen Storage Disease Approved by FDA - Connecticut Children's
When Cancer Patients Ask About Weed, Many Doctors Say Go For It – Houston Public Media
Doctor claims to cure pediatric cancer, critics skeptical
PHL Inno - Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing
Cancers, Free Full-Text
Texas judges clear Houston cancer doctor of most medical misconduct charges
Vaccines, Free Full-Text
FibroGen limited access to Duchenne muscular dystrophy drug after failed clinical trial. But mom says it works for her son. - San Francisco Business Times
de
por adulto (o preço varia de acordo com o tamanho do grupo)
